Evidence Details for RBPMS2
Basic Information Top
Gene Symbol: | RBPMS2 ( - ) |
---|---|
Gene Full Name: | RNA binding protein with multiple splicing 2 |
Band: | 15q22.31 |
Quick Links | Entrez ID:348093; OMIM: NA; Uniprot ID:RBPS2_HUMAN; ENSEMBL ID: ENSG00000166831; HGNC ID: 19098 |
Relate to Another Database: | SFARIGene; denovo-db |
Sequences Top
>RBPMS2|348093|nucleotide
ATGAGCAACCTGAAGCCGGACGGCGAGCACGGCGGCAGCACCGGCACCGGCTCCGGCGCGGGCTCCGGCGGCGCCCTGGAGGAGGAGGTCCGGACACTGTTTGTC
AGCGGCCTCCCTGTGGACATTAAACCCAGAGAACTCTACTTGCTCTTCCGGCCGTTCAAGGGGTATGAAGGGTCCCTGATCAAGCTCACTGCAAGACAGCCTGTT
GGTTTTGTGATCTTTGACAGCCGTGCAGGAGCAGAAGCGGCCAAGAATGCGCTGAACGGTATTCGCTTTGATCCCGAAAATCCACAGACTCTGAGGCTAGAGTTT
GCCAAAGCCAACACCAAGATGGCCAAGAGCAAGCTAATGGCAACTCCAAATCCCAGCAACGTGCACCCCGCCCTAGGAGCACACTTCATCGCACGGGACCCCTAT
GACCTGATGGGGGCTGCTCTGATCCCTGCATCCCCAGAGGCCTGGGCCCCCTACCCTTTGTACACCACAGAGCTGACCCCAGCCATCTCCCATGCTGCGTTCACC
TACCCAACTGCCACTGCCGCTGCCGCCGCCCTCCACGCTCAGGTGCGCTGGTACCCTTCCTCTGACACCACCCAGCAAGGATGGAAGTACCGTCAGTTCTGTTAG
Show »
ATGAGCAACCTGAAGCCGGACGGCGAGCACGGCGGCAGCACCGGCACCGGCTCCGGCGCGGGCTCCGGCGGCGCCCTGGAGGAGGAGGTCCGGACACTGTTTGTC
AGCGGCCTCCCTGTGGACATTAAACCCAGAGAACTCTACTTGCTCTTCCGGCCGTTCAAGGGGTATGAAGGGTCCCTGATCAAGCTCACTGCAAGACAGCCTGTT
GGTTTTGTGATCTTTGACAGCCGTGCAGGAGCAGAAGCGGCCAAGAATGCGCTGAACGGTATTCGCTTTGATCCCGAAAATCCACAGACTCTGAGGCTAGAGTTT
GCCAAAGCCAACACCAAGATGGCCAAGAGCAAGCTAATGGCAACTCCAAATCCCAGCAACGTGCACCCCGCCCTAGGAGCACACTTCATCGCACGGGACCCCTAT
GACCTGATGGGGGCTGCTCTGATCCCTGCATCCCCAGAGGCCTGGGCCCCCTACCCTTTGTACACCACAGAGCTGACCCCAGCCATCTCCCATGCTGCGTTCACC
TACCCAACTGCCACTGCCGCTGCCGCCGCCCTCCACGCTCAGGTGCGCTGGTACCCTTCCTCTGACACCACCCAGCAAGGATGGAAGTACCGTCAGTTCTGTTAG
Show »
>RBPMS2|348093|protein
MSNLKPDGEHGGSTGTGSGAGSGGALEEEVRTLFVSGLPVDIKPRELYLLFRPFKGYEGSLIKLTARQPVGFVIFDSRAGAEAAKNALNGIRFDPENPQTLRLEF
AKANTKMAKSKLMATPNPSNVHPALGAHFIARDPYDLMGAALIPASPEAWAPYPLYTTELTPAISHAAFTYPTATAAAAALHAQVRWYPSSDTTQQGWKYRQFC
Show »
MSNLKPDGEHGGSTGTGSGAGSGGALEEEVRTLFVSGLPVDIKPRELYLLFRPFKGYEGSLIKLTARQPVGFVIFDSRAGAEAAKNALNGIRFDPENPQTLRLEF
AKANTKMAKSKLMATPNPSNVHPALGAHFIARDPYDLMGAALIPASPEAWAPYPLYTTELTPAISHAAFTYPTATAAAAALHAQVRWYPSSDTTQQGWKYRQFC
Show »
Evidence summary Top
Click the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default.
Evidences | Syndromic Gene | GWAS | CNV | Linkage | Association | Expression | NGS de novo | NGS Mosaic | NGS Other | Low-Scale Gene Studies | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Score (No. of Studies) | No | 0 (0) | 1 (3) | 0 (0) | 0 (0) | 1 (1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (4) |
Syndromic Autism Gene Top
Genome-Wide Association Studies(By Ethnic Group) Top
CNV Studies Top
Reference | Source | Method | ADI-R | ADOS | Diagnosis | Family | Individual | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Simplex | Multiplex | Control | Affected | Control | Total | ||||||
Smith, 2000 | - | FISH | autism | - | - | - | - | 1 | - | 1 | ||
Wassink, 2001 | USA | Chromosomal analysis of G-band | autism | - | - | - | - | 278 | - | 278 | ||
Szatmari, 2007 | Europe, North America | SNP microarray | ASD | 1491 | - | - | - | - | - | 0 |
Linkage Studies Top
Low Scale Association Studies (by Ethnic Group) Top
Large Scale Expression Studies Top
Microarray Studies: 1
Reference | Source | Tissue | #Subjects (% Women) |
ADI-R | ADOS | Endo- pheno | Diagnosis | Normal Controls (% Women) |
Fold Change | Up/ Down | P/Q value | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Ghahramani Seno, 2010_1 | Unknown | lymphoblastoid cell-line | 20 (35.00%) | - | AD | 22 (13.64%) |
1.35 | Up | 0.134 | |||
|
Proteomics Studies:0
Reference | Source | Tissue | Platform | #Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Normal Controls(% Women) | |
---|---|---|---|---|---|---|---|---|---|
No Evidence. |
NGS de novo Mutation Studies Top
NGS Mosaic SNV Studies Top
NGS Other Studies Top
Low Scale Gene Studies Top
Contact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.